We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · May 12, 2020

Whole-Body Diffusion-Weighted MRI for Detection of Bone Metastases in mRCC Patients Treated With Angiogenesis Inhibitors

Acta Oncologica (Stockholm, Sweden)


Additional Info

Acta Oncologica (Stockholm, Sweden)
Whole-Body Diffusion-Weighted Magnetic Resonance Imaging for the Detection of Bone Metastases and Their Prognostic Impact in Metastatic Renal Cell Carcinoma Patients Treated With Angiogenesis Inhibitors
Acta Oncol 2020 Apr 16;[EPub Ahead of Print], B Beuselinck, S Pans, J Bielen, L De Wever, N Noppe, G Vanderschueren, F De Keyzer, M Baldewijns, E Lerut, A Laenen, A Verbiest, E Roussel, M Albersen, V Vandecaveye

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading